Jack Bendheim, President and CEO, 10% Owner at PHIBRO ANIMAL HEALTH CORP (PAHC), sold 42,240 shares at $52.88 ($2.3M) on 2026-03-24, disclosed to the SEC on 2026-03-26.
Scheduled sale ($2.3M) by President and CEO, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.88 | 6,523 | $345K | 14.8% |
| 2 | $52.88 | 6,523 | $345K | 14.8% |
| 3 | $53.59 | 517 | $28K | 1.2% |
| 4 | $53.59 | 517 | $28K | 1.2% |
| 5 | $55.28 | 1,572 | $87K | 3.7% |
| 6 | $55.28 | 1,572 |
| $87K |
| 3.7% |
| 7 | $56.00 | 4,916 | $275K | 11.8% |
| 8 | $56.00 | 4,916 | $275K | 11.8% |
| 9 | $56.86 | 552 | $31K | 1.3% |
| 10 | $56.86 | 552 | $31K | 1.3% |
| 11 | $56.79 | 6,760 | $384K | 16.5% |
| 12 | $56.79 | 6,760 | $384K | 16.5% |
| 13 | $57.17 | 280 | $16K | 0.7% |
| 14 | $57.17 | 280 | $16K | 0.7% |
| Total | $55.21 avg | 42,240 | $2.3M | 100% |
| Filing → |
| PAHC | SELL | 2026-04-23 | $1.2M | — | Filing → |
| PAHC | SELL | 2026-04-16 | $1.2M | — | Filing → |
| PAHC | SELL | 2026-03-31 | $1.5M | — | Filing → |